Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y ▼ | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insmed Inc. | 1.480% | 0.735% | 11.382% | 244.221% | 139.510% | 242.500% | 340.741% |
| ImmunityBio Inc. | -4.090% | -17.009% | -25.573% | 142.034% | -9.237% | -54.513% | 277.445% |
| Eledon Pharmaceuticals Inc. | 6.400% | -1.481% | 16.667% | 121.667% | 62.195% | -50.741% | -80.294% |
| Eli Lilly Corp. | -4.160% | -0.607% | -12.678% | 77.419% | 39.583% | 254.497% | 628.117% |
| Ardelyx Inc. | 7.540% | 7.309% | 12.851% | 50.407% | -3.979% | 293.617% | 152.790% |
| Intuitive Surgical Inc | -1.540% | 1.365% | 0.894% | 43.546% | 34.745% | 47.900% | 167.449% |
| Cardiff Oncology Inc. | -2.100% | -4.630% | 6.625% | 32.561% | 56.535% | -54.222% | 35.776% |
| Inogen Inc. | -0.580% | -4.494% | 18.056% | 21.429% | 71.371% | -87.121% | -83.831% |
| Acadia Healthcare | -4.030% | 0.000% | -4.032% | -16.197% | -15.603% | 14.423% | 124.444% |
| Cytomx Therapeutics Inc | -2.190% | -9.441% | 0.322% | -19.961% | -10.673% | -73.547% | -86.236% |
| MacroGenics Inc. | -6.060% | -31.294% | -12.180% | -21.435% | -61.067% | -83.557% | -73.531% |
| Stratec SE | -3.850% | -8.092% | -17.102% | -25.392% | -17.102% | -71.087% | -35.508% |
| SELLAS Life Sciences Group Inc | -7.990% | -0.559% | -2.555% | -28.705% | 9.538% | -85.167% | -86.404% |
| Inventiva SA | 1.180% | -2.036% | -22.401% | -39.694% | -47.001% | -81.174% | - |
| Enlivex Therapeutics Ltd. | 1.670% | -3.175% | -2.400% | -48.739% | -45.536% | -80.787% | -93.444% |
| Evotec SE | -4.330% | -6.786% | -11.806% | -64.730% | -62.055% | -76.494% | -68.065% |
| Coherus Bioscien. | -6.020% | -21.368% | -4.351% | -68.676% | -59.145% | -88.811% | -91.917% |
| DBV Technologies S.A. | -4.100% | -10.696% | 5.263% | -70.847% | -54.617% | -90.326% | -94.819% |
| Revance Therapeutics Inc. | -2.560% | - | - | - | - | - | - |